Sharon O'Keefe - 11 Nov 2026 Form 4 Insider Report for Covista Inc. (CVSA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
13 Nov 2026, 16:33:59 UTC
Prior SEC filing
30 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Lawrence C. Bachman, attorney-in-fact for Ms. O'Keefe
Filing notes and source

Key filing fact

Sharon O'Keefe filed Form 4 for Covista Inc. (CVSA) on 13 Nov 2026.

Key facts

  • This page summarizes Sharon O'Keefe's Form 4 filing for Covista Inc. (CVSA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Nov 2026, 16:33.

Change

  • Previous filing in this sequence was filed on 30 Jul 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001544333 Primary reporting owner

O'KEEFE SHARON

Relationship
Director
Address
233 S. WACKER DRIVE, SUITE 800, CHICAGO
Signature
/s/ Lawrence C. Bachman, attorney-in-fact for Ms. O'Keefe
Signature date
13 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CVSA transaction

Common Stock

Award

Transaction value
Shares
+1,255
Change %
+7.6%
Price
$119.55*
Shares after
17,852
Date
11 Nov 2026
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The common stock is a restricted stock unit which represents a right to receive one share of common stock for each restricted stock unit. Stock units vest 100% on the one year anniversary of the transaction date.

Footnote F2

The number of restricted stock units awarded to the Reporting Person was determined by dividing the total dollar value of director compensation awarded to the Reporting Person by $119.55, the closing price of CVSA common stock on November 11, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .